UNSPSC 85492804: Revision of extraluminal device in great vessel, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of extraluminal device in great vessel, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WY3CZ

UNSPSC 85492804 Revision of extraluminal device in great vessel, percutaneous approach is a Commodity code that, based on recent state and local solicitations, does not align with actual procurement activity under this designation. The code nominally describes a specific surgical procedure involving vascular devices, yet the recent opportunities tagged to it cover occupational medical surveillance, disability medical evaluations, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing, and emergency medical services for detained youth—none of which involve extraluminal device revision. State and local procurement offices appear to have misclassified these health services and staffing opportunities when assigning codes, creating a mismatch between the code's clinical scope and the work actually being bought.

The six recent solicitations across Arizona, California, Florida, and Washington originate from diverse issuing bodies including city retirement offices, municipal employee benefits programs, state transportation departments, county health systems, juvenile probation departments, and county human resources divisions. Representative opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 five-year contract), the City of Long Beach's RFP for surgical carve-out benefits management (due October 7, 2026, targeting Anthem Blue Cross PPO members), and the Washington State Department of Transportation's RFP for occupational medical surveillance across 14 ferry system locations (due October 9, 2026). Given the systematic mismatch between the code's nominal scope and the actual services represented, this code shows little relevant recent activity for vendors focused on extraluminal vascular device revision or related implantable technology.